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Abstract
Background Metabolic syndrome (MetS) is a cluster metabolic disorder that includes central obesity, insulin resistance, 
hypertension, and dyslipidemia, and is highly associated with an increased risk of developing non-communicable diseases 
(NCDs). This study aimed to compare the reliability of anthro-metabolic indices [visceral adiposity index (VAI), body 
roundness index (BRI), and a body shape index (BSI), body adiposity index (BAI), lipid accumulation product (LAP), waist 
to hip ratio, and waist to height ratio] in predicting MetS in Iranian older people.
Methods This cross-sectional study was conducted based on the data of 2426 adults aged ≥60 years that participated in 
the second stage of the Bushehr Elderly Health (BEH) program, a population-based prospective cohort study being con-
ducted in Bushehr, Iran. MetS was defined based on the revised National Cholesterol Education Program Adult Treatment 
Panel III (NCEP-ATP III) criteria. The receiver operating characteristic (ROC) curve analysis was used to assess predictive 
performance of anthro-metabolic indices and determine optimal cutoff values. Logistic regression analysis was applied to 
determine the associations between MetS and indices.
Results 2426 subjects (48.1% men) with mean ± SD age of 69.34 ± 6.40 years were included in the study. According to ATP 
III criteria, 34.8% of men and 65.2% of women had MetS (P < 0.001). Of the seven examined indices, the AUCs of VAI 
and LAP in both genders were higher than AUCs of other anthro-metabolic indices. Also, in general population, VAI and 
LAP had the greatest predictive power for MetS with AUC 0.87(0.86–0.89) and 0.87(0.85–0.88), respectively. The lowest 
AUC in total population belonged to BSI with the area under the curve of 0.60(0.58–0.62). After adjusting for potential 
confounders (e.g. age, sex, education, physical activity, current smoking) in the logistic regression model, the highest OR in 
the total population was observed for VAI and LAP, which was 16.63 (13.31–20.79) and 12.56 (10.23–15.43) respectively. 
The lowest OR for MetS was 1.93(1.61–2.30) for BSI.
Conclusion This study indicated that both VAI and LAP are the most valuable indices among the anthro-metabolic indices 
to identify MetS among the elderly in both genders. So, they could be used as proper assessment tools for MetS in clinical 
practice. However, the cost-benefit of these indices compared to the ATP III criteria need further studies.
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Introduction
Metabolic syndrome (MetS) variously known also as “syn-
drome X, insulin resistance syndrome, Reaven syndrome, 
and the deadly quartet” is a cluster metabolic disorder that 
includes central obesity, insulin resistance, hypertension, 
and dyslipidemia, and is powerfully associated with an 
increased risk of developing non-communicable diseases 
(NCDs) such as type 2 diabetes, cardiovascular disease 
(CVD), nonalcoholic fatty liver disease, and stroke [1–3]. 
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A systematic review and meta-analysis showed that the 
prevalence of MetS according to Adult Treatment Panel-III 
(ATP-III) / National Cholesterol Education Program (NCEP) 
criteria is 23.8% for >18 adults in Iran [4]. furthermore, in a 
cohort study the prevalence of metabolic syndrome based on 
the definition of ATP III/ NCEP was estimated to be approxi-
mately 33.82% in the Iranian elderly [5].
Obesity as an independent risk factor for metabolic 
syndrome, results from an imbalance in energy intake and 
consumption, which is manifested by the accumulation 
of excess fat in the body [6]. Besides the advantages and 
disadvantages of anthropometric indices, these indices are 
used as low-cost and affordable methods to assess body fat 
mass, obesity and predict metabolic syndrome [7]. Body 
mass index (BMI) or cutlet index is the most common index 
which is used in assessing the weight to height ratio [8]. 
It is noteworthy that interpretation of BMI in people with 
a height less than 150 cm should be done carefully [9]. In 
risk assessment, waist circumference (WC) and waist-to-hip 
ratio (WHR) measurements are used to assess abdominal 
or central obesity which is considered as a complement to 
BMI [10, 11]. The waist-to-height ratio (WHtR) indicates 
the distribution of adipose tissue, and compared to BMI it 
is a better indicator of abdominal obesity, and also higher 
WHtR values are associated with a higher risk of metabolic 
syndrome [12]. Body shape index (BSI),independent of 
BMI, is defined based on waist circumference, height, and 
weight [13], and also better than BMI, could predict prema-
ture death and the onset of metabolic syndrome [14, 15]. 
Body roundness index (BRI) is a new anthropometric index 
that is calculated based on waist circumference and height 
which is developed to predict both visceral body fat [14, 16].
The newly defined lipid accumulation product (LAP) 
index is a measure of central fat accumulation. It predicts 
the risk of metabolic syndrome, and different studies have 
shown that compared to BMI, LAP is a better index for pre-
dicting type 2 diabetes and CVD [17, 18]. visceral fat index 
(VAI) is another novel indicator, which is defined based on 
a combination of WC, BMI, triglycerides, and High-density 
lipoprotein- cholesterol (HDL-C) measurements, for men 
and women separately [19]. Body adiposity index (BAI) is 
a new surrogate measure of body fat and more accurately 
could predict the onset of CVD and metabolic syndrome 
than BMI [20, 21].
Numerous studies have shown that each of the current 
and new anthropometric indices has reported contradictory 
results for predicting metabolic syndrome and some dif-
ferences in cut points among different ethnicities [22–26]. 
Accordingly, considering the importance of determining the 
cut-off point of anthropometric indices to predict the risk of 
metabolic syndrome, this study aims to identify the optimal 
cut-off points for by VAI, BRI, BAI, LAP, and BSI indices 
and compare and evaluate the accuracy and relevance of 




Current study is a cross-sectional study based on the sec-
ond stage of the BEH program. In brief, The BEH (Bushehr 
Elderly Health) program is a population-based prospec-
tive cohort study being performed in Bushehr, a southern 
province in Iran [27]. In short, using a multistage, strati-
fied cluster sampling method an overall of 3000 persons 
aged ≥60 years were recruited. In the second stage of the 
BEH program, 2426 participants were included to investi-
gate musculoskeletal health [28]. The study protocol was 
reviewed and approved by the Research Ethics Committee 
of both Bushehr University of Medical Sciences and Endo-
crinology and Metabolism Research Institute and also eth-
ics committee of Tehran University of Medical Sciences. 
All study participants completed written informed consent 
before the study.
Data collection
Data were collected through comprehensive questionnaires 
including sociodemographic characteristics, general health, 
medical history, and lifestyle data during an interview that 
was performed by a trained interviewer. A fixed stadiometer 
and a digital scale were used for the measurements of height 
and weight, respectively. Waist circumference (WC) was 
measured at a point midway between the iliac crest and the 
lowest rib in the standing position crest and the hip circum-
ference was measured at the widest part of the hips. Body 
mass index (BMI) was calculated by the formula weight (kg) 
/ [height  (m2)]. Blood pressure (BP) was measured twice by 
a standard mercury sphygmomanometer after 15 min of rest 
in the seated position and then the mean of the two meas-
urements was considered as the participant’s systolic and 
diastolic blood pressures. The physical activity level was 
evaluated by a standard questionnaire based on metabolic 
equivalent (MET) levels [29].
Patients’ lipid profile and blood glucose were measured 
by assessing venous samples, drawn after overnight fasting. 
Using the enzymatic colorimetric method with cholesterol 
esterase and cholesterol oxidase, total cholesterol (TC) was 
determined. Details for the measurements of fasting blood 
glucose (FBG), high-density lipoprotein (HDL-C), low-den-
sity lipoprotein cholesterol (LDL-C), and triglyceride (TG) 
were reported elsewhere [28].
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Definition of variables
MetS was defined based on the revised National Cho-
lesterol Education Program Adult Treatment Panel 
III (NCEP-ATP III) criteria by the presence of three 
or more of the following criteria: abdominal obesity 
[WC > 102 cm (men) or > 88 cm (women)]; TG ≥ 150 mg/
dl; HDL-C < 40  mg/dl (men) or < 50  mg/dl (women); 
blood pressure ≥ 130/85 mmHg or receiving treatment for 
previously diagnosed hypertension. FBS ≥ 100 mg /dl or 
use of medication to treat diabetes. [30].
Current smoking was defined as smoking cigarettes or 
water pipes at the study time. Physical activity level was 
assessed based on metabolic equivalent (MET) levels were 
ranged on a scale from sleep/rest to high-intensity physi-
cal activities. Participants were grouped into 2 groups as 
sedentary/low activity (inactive group) and active group, 
according to the MET values [28].
The following formulas were applied to calculate the 
anthro-metabolic indices [13, 19, 31–33]:
• 
BSI (Body shape index) = WC (m)∕
[
BMI2∕3 ∗ Height (m)1∕2
]
• 





• LAP (Lipid Accumulation Production)
• VAI(Viseral Adipiosity Index)
• 











Baseline characteristics of the participants were reported 
based on the MetS status in men and women separately. 
Continuously-distributed variables were described by report-
ing their mean ± standard deviations and were compared 
using the independent t-test, Categorical data, explained by 
percentages, were tested by chi2 or Fisher’s exact.
Men ∶
[





∗ [WC (cm) − 58]










































To assess the predictive capacity of the anthro-metabolic 
indices in identifying MetS, the receiver operating charac-
teristic (ROC) curves were applied. Areas under the curves 
(AUCs) and 95% confidence intervals (CIs) were calculated 
to compare the predictive value of the various indices in 
identify MetS. The cutoff point of each indicator was deter-
mined based on the maximum value of Youden’s index [34].
Logistic regression analyses were performed to determine 
the associations between MetS and anthro-metabolic indices, 
odds ratios (ORs) with 95% confidence intervals in crude 
and adjusted models were reported.
P values <0.05 were considered as statistically signifi-
cant. We used the Stata 14 software (StataCorp. 2015. Stata 
Statistical Software: Release 14. College Station, TX: Stata-
Corp LP) to perform the statistical analyses.
Results
A total of 2426 subjects (48.1% men) with mean ± SD age 
of 69.34 ± 6.40 years were included in the study. Table 1 
illustrates the baseline characteristics of participants includ-
ing anthropometric and biochemical measurements based 
on sex and MetS category. According to ATP III criteria, 
34.8%of men and 65.2% of women had MetS (P < 0.001). 
Men and women with MetS had higher BMI, waist and hip 
circumferences than people without MetS (P < 0.001). Also, 
people with Mets in both genders had higher weight and 
height compared to participants without MetS. There were 
significant differences in the mean of FBG, triglyceride, and 
HDL-C between MetS (+) and MetS (−) in both genders 
(P < 0.001).
Table 2 presents the mean of anthro-metabolic indices 
according to have MetS in both genders. The mean of all 
anthro-metabolic indices were higher in MetS (+) than MetS 
(−) in men and women (P < 0.001).
Table 3 shows the cut-off points of anthro-metabolic 
indices in predicting MetS with sensitivity, specific-
ity, and AUC for gender category and total participants. 
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The optimal cutoff point for BSI was 0.088 (sensitivity 
66.55%, specificity 46.68%) in women and 0.087 (sen-
sitivity 66.30%, specificity 49.16%) in men, for BRI was 
5.42 (sensitivity 63.44%, specificity 72.61%) in men and 
5.35 (sensitivity 89.40%, specificity 40.79%) in women 
in prediction of MetS. Also, the optimal cutoff point for 
identifying Mets for VAI was 2.31 in women with 70.32% 
sensitivity and 87.71% specificity, and 1.88 in men with 
77.97% sensitivity and 81.46% specificity. The optimal 
cutoff points for BAI and LAP were 26.89 (sensitivity 
78.85%, specificity 38.06%) and 49.31 (sensitivity 74.00%, 
specificity 83.71%) in men, respectively and also 36.37 
(sensitivity 65.37%, specificity 52.58%) and 52.39 (sensi-
tivity 76.09%, specificity 76.90%) in women, respectively.
Among women, the Waist to height ratio and Waist to hip 
ratio cut points were 0.60 (sensitivity 87.87%, specificity 
41.28%) and 0.92 (sensitivity 75.62%, specificity 44.72%) 
respectively, and 0.60 (sensitivity 61.89%, specificity 
73.46%) and 0.97 (sensitivity 74.89%, specificity 60.39%), 
respectively in men.
Of the seven examined indices, the AUCs of VAI and 
LAP in both genders were higher than other anthro-meta-
bolic indices. Also, among the general population, VAI and 
LAP had the greatest predictive power for MetS with AUC 
Table 1  General characteristics of participants by having MetS in both genders
Data are presented as mean ± standard deviation or number(percent)
MetS Metabolic Syndrome, BMI body mass index, WC waist circumference, FBG fasting blood glucose, HDL-C High Density Lipoprotein- 
Cholesterol, LDL-C Low Density Lipoprotein-Cholesterol, TG triglycerides, HTN hypertension










Age(Years) 69.06 ± 6.23 69.85 ± 6.56 0.041 68.72 ± 5.83 70.08 ± 7.25 <0.001
Education years 7.09 ± 5.04 7.38 ± 5.25 0.339 3.17 ± 3.93 3.52 ± 4.24 0.160
Physical activity 93(20.5) 178(25.0) 0.075 197(23.2) 87(21.4) 0.469
Current smoking 92(20.3) 180(25.3) 0.048 147(17.3) 84(20.7) 0.152
Weight (Kg) 78.13 ± 11.65 68.58 ± 11.39 <0.001 69.15 ± 12.24 61.31 ± 13.36 <0.001
Height (Cm) 166.49 ± 6.31 165.48 ± 6.28 0.008 152.54 ± 5.84 151.60 ± 6.63 0.011
WC(Cm) 102.96 ± 9.65 93.34 ± 10.54 <0.001 103.09 ± 11.08 94.27 ± 13.26 <0.001
Hip circumference (Cm) 102.19 ± 7.03 97.51 ± 7.52 <0.001 107.42 ± 10.74 101.72 ± 11.21 <0.001
BMI (Kg/m2) 28.15 ± 3.70 25.02 ± 3.73 <0.001 29.73 ± 5.14 26.58 ± 5.12 <0.001
FBG (mg/dl) 122.00 ± 48.58 93.47 ± 29.00 <0.001 117.05 ± 49.85 88.36 ± 19.71 <0.001
TG (mg/dl) 173.43 ± 77.99 102.74 ± 42.61 <0.001 161.97 ± 77.02 97.73 ± 29.31 <0.001
Cholesterol (mg/dl) 174.13 ± 43.69 172.79 ± 38.94 0.587 188.23 ± 47.83 195.14 ± 39.93 0.012
HDL-C (mg/dl) 37.50 ± 8.51 46.64 ± 9.45 <0.001 44.80 ± 9.81 56.53 ± 10.80 <0.001
LDL-C (mg/dl) 102.40 ± 36.85 106.00 ± 33.37 0.085 111.33 ± 41.35 119.46 ± 35.50 0.001
HTN 372(81.9) 451(63.4) <0.001 721(84.9) 224(55.0) <0.001
Table 2  Characteristics of 
anthro-metabolic indices among 
studied population stratified by 
MetS
Data are presented as mean ± standard deviation
MetS Metabolic syndrome, BSI body shape index, BAI body adiposity index, BRI body roundness index, 
VAI visceral adiposity index
Men Women
Variables MetS(+) MetS(−) P value MetS(+) MetS(−) P value
BSI 0.0884 ± 0.004 0.0869 ± 0.005 <0.001 0.896 ± 0.006 0.0883 ± 0.006 0.001
BAI 29.66 ± 3.80 27.88 ± 3.87 <0.001 39.17 ± 6.62 36.57 ± 6.06 <0.001
BRI 5.94 ± 1.43 4.73 ± 1.31 <0.001 7.40 ± 1.97 6.09 ± 2.02 <0.001
LAP 73.07 ± 36.07 33.45 ± 19.50 <0.001 82.37 ± 44.08 40.06 ± 19.30 <0.001
Waist to hip ratio 1.01 ± 0.06 0.96 ± 0.11 <0.001 0.96 ± 0.07 0.93 ± 0.07 <0.001
Waist to height ratio 0.62 ± 0.06 0.56 ± 0.06 <0.001 0.68 ± 0.08 0.62 ± 0.09 <0.001
VAI 3.06 ± 1.73 1.39 ± 0.71 <0.001 3.60 ± 2.46 1.62 ± 0.66 <0.001
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0.87(0.86–0.89) and 0.87(0.85–0.88), respectively. The low-
est AUC in total people was observed in BSI with the area 
under the curve of 0.60(0.58–0.62). (Table 3, Fig. 1).
The results of logistic regression of MetS and each of 
the anthro-metabolic indices, one at a time, were illustrated 
in Table 4. After adjusting for the demographic confound-
ers, the highest odds ratio (OR) for MetS in the total pop-
ulation was observed in VAI and LAP, which were 16.63 
(13.31–20.79) and 12.56 (10.23–15.43) respectively. The 
lowest OR for MetS was 1.93(1.61–2.30) based on BSI. 
Since the interaction between sex and waist to height ratio 
in predicting the MetS was significant sex-specific ORs 
were calculated, the OR of waist to height ratio in women 
was higher than men [OR: 5.90(95%CI: 4.37, 7.98) and 
4.42(95% CI: 3.42, 5.71) in women and men, respectively].
Discussion
Anthro-metabolic indices have been introduced as effective 
indicators to predict MetS in clinical setting [35]. However, 
differences in the inapplicability of the best predictive index 
from different countries and ethnic groups make it necessary 
to find an appropriate cut-off value for separate populations 
[35, 36]. In this study, more than half of the population had 
metabolic syndrome. We discovered that VAI and LAP were 
the strongest predictors of MetS among Iranian elderly aged 
≥60 years. Other anthropometric indices showed a weak 
sensitivity or specificity (<70%) to identify MetS in elderly 
men and women. The results did not change after controlling 
for potential confounding factors.
Our reported prevalence of MetS was lower than that 
reported in Turkey [37] and Colombia [38]; however, the 
lower prevalence was reported in Brazil [39] and China [40]. 
Our findings are in line with previous nationwide studies 
with an alarming prevalence among populations more than 
65 years, regardless of the defined criteria [41, 42]. Mets 
were estimated from 31.1% to 74% by using different cri-
teria, including ATP III, IDF, AHA/NHLBI, and JIS [42, 
43]. Such a wide variation could be attributed to the cut-off 
points used to define central obesity, which is affected by 
ethnicity-specific values [44].
VAI is a gender-specific mathematical model formulated 
based on both anthropometric (BMI and WC) and functional 
(TG, HDL-C) parameters [19]. Sufficient evidence suggests 
abdominal obesity as a principal risk factor for metabolic 
diseases such as diabetes mellitus and cardiovascular dis-
eases [45, 46]. Waist circumference is a main clinical index 
Table 3  Cut points, sensitivity, 
specificity, and area under curve 
of anthro-metabolic indices to 
identify metabolic syndrome 
among participants in the BEH 
Study
BSI body shape index, BAI body adiposity index, BRI body roundness index, VAI visceral adiposity index
Anthro-metabolic Indices Cut-Points Sensitivity (95% CI) Specificity (95% CI) AUC (95% CI)
Total
 BSI 0.089 52.34(49.59–55.08) 63.45(60.55–66.28) 0.60(0.58–0.62)
 BAI 32.04 65.92(63.28–68.50) 65.42(62.55–68.20) 0.70(0.68–0.72)
 BRI 5.72 73.06(70.56–75.46) 68.10(65.28–70.82) 0.76(0.74–0.78)
 LAP 49.31 77.90(75.54–80.12) 79.45(76.96–81.78) 0.87(0.85–0.88)
 Waist to hip ratio 0.98 50.04(47.29–52.79) 70.24(67.47–72.91) 0.63(0.61–0.65)
 Waist to height ratio 0.61 74.29(71.03–76.64) 66.85(64.00–69.60) 0.76(0.74–0.78)
 VAI 2.10 72.14(69.62–75.56) 84.27(82.00–86.36) 0.87(0.86–0.89)
Men
 BSI 0.087 66.30(61.75–70.64) 49.16(45.42–52.90) 0.59(0.56–0.62)
 BAI 26.89 78.85(74.81–82.52) 38.06(34.48–41.74) 0.62(0.59–0.65)
 BRI 5.42 63.44(58.82–67.88) 72.61(69.18–75.86) 0.74(0.71–0.76)
 LAP 49.31 74.00(69.72–77.99) 83.71(80.79–86.35) 0.87(0.85–0.89)
 Waist to hip ratio 0.97 74.89(70.64–78.82) 60.39(56.69–64.01) 0.73(0.70–0.76)
 Waist to height ratio 0.60 61.89(57.25–66.38) 73.46(70.05–76.67) 0.74(0.71–0.76)
 VAI 1.88 77.97(73.88–81.70) 81.46(78.41–84.25) 0.86(0.84–0.88)
Women
 BSI 0.088 66.55(63.26–69.72) 46.68(41.75–51.66) 0.56(0.53–0.60)
 BAI 36.37 65.37(62.06–68.57) 52.58(47.60–57.52) 0.62(0.58–0.65)
 BRI 5.35 89.40(87.13–91.39) 40.79(35.97–45.74) 0.68(0.65–0.72)
 LAP 52.39 76.09(73.07–78.92) 76.90(72.50–80.91) 0.85(0.82–0.87)
 Waist to hip ratio 0.92 75.62(72.59–78.47) 44.72(39.82–49.69) 0.64(0.61–0.67)
 Waist to height ratio 0.60 87.87(85.48–89.99) 41.28(36.45–46.23) 0.68(0.65–0.72)
 VAI 2.31 70.32(67.12–73.37) 87.71(84.13–90.74) 0.86(0.84–0.88)
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to indirectly measure the increased visceral fat [47]. How-
ever, WC may not be useful for differentiating between 
subcutaneous and visceral fat mass [48]. The VAI has been 
reported independently associated with adipose tissue dys-
function and related cardio- and cerebrovascular events [19]. 
We found that VAI would have the best predictive capacity 
for MetS in an elderly population of Southern Iran. The same 
findings were reported in Mazandaran, a Northern province 
of Iran, with the related AUC of 0.85 to 0.902 [49]. VAI and 
WC and WHtR were also reported as the best predictors of 
MetS components among Peruvians aged 15 or older [50].
We present further findings on the predictive capacity 
of LAP in elderly people. In some populations, LAP was 
found to be a beneficial predictor of multiple health condi-
tions, including CVDs [51] and chronic kidney diseases 
Fig. 1  Receiver-operating characteristic (ROC) analysis of anthro-metabolic indices versus vs. reference line for prediction metabolic syndrome 
in total (A), women (B) and men (C)
Table 4  Logistic Regression of MetS on Cutoff Points of each anthro-
metabolic indices
Model 1: crude model, Model 2: adjusted for Age, sex, education, 
Physical activity, current smoking
BSI body shape index, BAI body adiposity index, BRI body roundness 
index, VAI visceral adiposity index





Waist to hip ratio 3.71(3.12–4.40) 3.50 (2.93–4.17)
Waist to height ratio 6.45(5.38–7.74) 5.89(4.89–7.10)
VAI 13.91(11.38–17.00) 16.63(13.31–20.79)
Journal of Diabetes & Metabolic Disorders 
1 3
[52]. In middle-aged and older people of Korea, LAP 
could predict MetS and exhibited the greatest accuracy 
of diagnosis (AUC = 0.92) [53]. In Japanese adults, this 
parameter was found to have good power in the prediction 
of both coronary artery disease and MetS [54]. Such a 
predicting ability of LAP was also documented in adults 
from China and older adults from Taiwan [18, 55]. Reflect-
ing visceral adiposity level, LAP gives more advantages 
to predict MetS [56]. The integration of triglyceride in the 
LAP formula provides a practical tool to recognize a high 
amount of visceral fat in individuals [18].
Our study has some limitations. The results are 
restricted to healthy populations in Southern Iran aged 60 
and over; therefore, these may not apply to other popula-
tions. Also, the absence of a uniform international classi-
fication for MetS limits the comparison of results to other 
studies. Further, calculation of modern anthropometric 
indices could involve measurement errors, which may 
bias the results; however, we emphasize that all data were 
collected preciously with independent trained personnel. 
Despite limitations, several strengths can be accounted 
for in the present work. First, it was a population-based 
study with a large number of elderly participants. The data 
are representative of a large sample of Iranian people and 
randomly selected from a cohort study which minimizes 
the selection bias. Moreover, several potential confounders 
were taken into account.
Conclusions
In conclusion, this study indicated that VAI and LAP are the 
most valuable indices among the considered anthro-meta-
bolic indices to identify MetS among the elderly. Although, 
the VAI formula includes more defining variables of MetS 
and there is no big advantage for using VAI instead of ATP 
III criteria in terms of cost. While, LAP can be easily calcu-
lated through routine laboratory tests and simple anthropo-
metric measurements, and therefore can be used as relevant 
assessment tools for MetS in clinical practice. However, the 
cost-benefit for using this index compared to the ATP III 
criteria need further studies.
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